Daejeon, South Korea

Kyu Man Oh

USPTO Granted Patents = 8 

Average Co-Inventor Count = 14.0

ph-index = 5

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 2012-2021

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Kyu Man Oh: Innovator in Self-Immolative Compounds

Introduction

Kyu Man Oh is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that incorporate self-immolative groups. With a total of eight patents to his name, his work has the potential to impact various applications in medicine and biotechnology.

Latest Patents

Among his latest patents, Kyu Man Oh has developed compounds that comprise a self-immolative group. These compounds may include proteins, such as oligopeptides, polypeptides, or antibodies, which have substrate-specificity for a target. Additionally, these compounds can incorporate active agents, including drugs, toxins, ligands, or detection probes, each possessing specific functions or activities. This innovative approach opens new avenues for targeted therapies and diagnostics.

Career Highlights

Kyu Man Oh is currently associated with Legochem Biosciences, Inc., where he continues to advance his research and development efforts. His expertise in self-immolative compounds has positioned him as a key figure in the field, contributing to the growth of innovative solutions in biochemistry.

Collaborations

Kyu Man Oh has collaborated with notable colleagues, including Yong Zu Kim and Tae Kyo Park. These partnerships have fostered a collaborative environment that enhances the research and development of new compounds.

Conclusion

Kyu Man Oh's work in the field of self-immolative compounds exemplifies the innovative spirit of modern science. His contributions are paving the way for advancements in targeted therapies and diagnostics, showcasing the importance of research in improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…